Human mesenchymal stem cells are resistant to Paclitaxel by adopting a non-proliferative fibroblastic state.
Human mesenchymal stem cell (hMSC) resistance to the apoptotic effects of chemotherapeutic drugs has been of major interest, as these cells can confer this resistance to tumor microenvironments. However, the effects of internalized chemotherapeutics upon hMSCs remain largely unexplored. In this stud...
Main Authors: | Dale B Bosco, Rachael Kenworthy, Diego A R Zorio, Qing-Xiang Amy Sang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4452335?pdf=render |
Similar Items
-
A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis.
by: Dale B Bosco, et al.
Published: (2017-01-01) -
Mesenchymal Stem Cell-Like Properties in Fibroblasts
by: Yuqiao Chang, et al.
Published: (2014-08-01) -
Dickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation
by: Yan Li, et al.
Published: (2016-01-01) -
Fibroblasts as a practical alternative to mesenchymal stem cells
by: Thomas E. Ichim, et al.
Published: (2018-07-01) -
MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
by: M. M. Zafranskaya, et al.
Published: (2014-07-01)